Check Out BioWorld Today

 

 

Having trouble viewing images? View in web browser Dear Colleague- A multi-national technology giant jumps into the biotech sector with a $300M play. A new treatment for anemia associated with chronic kidney disease faces a key FDA hurdle. A research institute flaunts convention with pay-to-play clinical trials. A European company developing a unique antibody program nets $37M in Series B financing. Big biotech stories – all in one week. Did you get all of the details? Subscribers to BioWorld Today did. Delivered to your desktop every single business day, BioWorld Today gives you all the news you need to know to make good business decisions in the day ahead, you’ll learn: What your competitors are doing … so you can easily identify opportunities and threats. Where the smart money is going … where top investors are placing their bets and who is raising funds. The latest technological innovations and discoveries … to clinical study results across the industry. What the FDA and Congress are up to… so you can prepare for coming changes, and recent approvals. Start your Risk-Free subscription today and save over 50%! Best Regards, Jennifer Boggs Assistant Managing Editor, BioWorld Today    For questions or comments call Customer Service at 404-262-5547 Get Connected!

You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services. If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here. BioSpace 6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S. (888) BIOSPACE